[Inhibitory effect of anluohuaxianwan on experimental hepatic fibrosis in rats]
- PMID: 20128961
- DOI: 10.3760/cma.j.issn.1007-3418.2010.01.003
[Inhibitory effect of anluohuaxianwan on experimental hepatic fibrosis in rats]
Abstract
Objective: To investigate the effects of anluohuaqianwan on experimental hepatic fibrosis induced by dimethyl nitrosamine (DMN) in rats.
Methods: 36 male SD rats were randomly dividied into three groups: model group, normal group, anluohuaqianwan group. The rats in the three groups were treated with DMN daily for 4 weeks. The liver function was detected using auto biochemistry analyzer, the serum HA, LN, IV-C, PIIIP were detected by immunoradiometry, the histopathology was observed in the left liver lobe after HE staining, the expression of matrix metalloproteinase-2 (MMP-2) in liver tissue were detected by immunohistochemistry.
Results: The serum levels of ALT, AST, ALP, TP, ALB and the contents of HA, LN, IV-C in model group were significantly increased compared to these in the normal group (P less than 0.01). The serum levels of ALT, AST and the contents of HA in anluohuaqianwan group were significantly lower than those in the model group (P less than 0.01). The liver MMP-2 in the model group was significantly increased compared to that in the normal group (P less than 0.05). The expression of MMP-2 in liver tissue of model group was lower than that in the anluohuaqianwan group (P less than 0.05).
Conclusion: Anluohuaqianwan can inhibit liver fibrosis in rats induced by DMN.
Similar articles
-
[Effect of Fuzheng Jiangan formula on liver fibrosis induced by albumin in rats].Zhongguo Zhong Yao Za Zhi. 2006 Nov;31(22):1890-3. Zhongguo Zhong Yao Za Zhi. 2006. PMID: 17285992 Chinese.
-
[Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].Zhonghua Yi Xue Za Zhi. 2006 Sep 26;86(36):2563-6. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17198567 Chinese.
-
[Protective effect of ganfukang capsule on hepatocytes in rats with experimental hepatic fibrosis].Zhong Yao Cai. 2004 Jun;27(6):428-9. Zhong Yao Cai. 2004. PMID: 15524298 Chinese.
-
[Advances of mechanism research on treatment of experimental liver fibrosis with traditional Chinese medicine].Zhong Xi Yi Jie He Xue Bao. 2003 Jul;1(2):142-5. doi: 10.3736/jcim20030218. Zhong Xi Yi Jie He Xue Bao. 2003. PMID: 15339591 Review. Chinese.
-
[Progress in experimental study on inhibitory effect of traditional Chinese medicine on liver fibrosis].Zhong Xi Yi Jie He Xue Bao. 2006 Mar;4(2):206-10. doi: 10.3736/jcim20060221. Zhong Xi Yi Jie He Xue Bao. 2006. PMID: 16529703 Review. Chinese. No abstract available.
Cited by
-
Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis.Front Pharmacol. 2023 Mar 21;14:1159222. doi: 10.3389/fphar.2023.1159222. eCollection 2023. Front Pharmacol. 2023. PMID: 37025490 Free PMC article.
-
Preclinical Models for Investigation of Herbal Medicines in Liver Diseases: Update and Perspective.Evid Based Complement Alternat Med. 2016;2016:4750163. doi: 10.1155/2016/4750163. Epub 2016 Jan 28. Evid Based Complement Alternat Med. 2016. PMID: 26941826 Free PMC article. Review.
-
Liver cirrhosis: molecular mechanisms and therapeutic interventions.MedComm (2020). 2024 Sep 17;5(10):e721. doi: 10.1002/mco2.721. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39290252 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous